All Press Releases for July 27, 2022

[PANGYO ISSUE] Pangyo Technovalley Weekly News, News from the third week of July

* LIG Nex1 unveils 2.75-Inch Low-Cost Guided Imaging Rocket during RIMPAC * President Yoon visits Pangyo Information Protection Cluster * SK Bioscience's "domestic no. 1 vaccine" effective against the omicron variant

    LOS ANGELES, CA, July 27, 2022 /24-7PressRelease/ -- Weekly News Video Briefing

No.1 Issue - LIG Nex1 introduced the 2.75-inch Low-Cost Guided Imaging Rocket during the Rim of the Pacific (RIMPAC) exercise, the world's largest maritime exercise organized by the U.S.

RIMPAC, which marks its 28th anniversary this year, is a drill conducted by the U.S. Navy to enhance the ability to protect maritime routes and interoperate allies' military capabilities among Pacific island countries. It is also a venue for networking among each country's navies as well as for promotion for countries targeting the U.S., the world's largest defense market.

LIG Nex1 said that it received great attention from navies of each country by displaying a low-cost guided imaging rocket that can be applied to vessels such as unmanned surface vehicles at the training site during RIMPAC.

No.2 Issue - President Yoon Suk-yeol strongly expressed his government's commitment to strengthen cyber security and raise the pride of workers in the field of personal information protection on the 13th.

President Yoon, who attended the 11th Information Protection Day ceremony held at Pangyo Information Protection Cluster, stressed that cybersecurity is key to national security and explained the government's policy direction to strengthen cybersecurity in South Korea.

Regarding responding to the global rise in cyber security threats, President Yoon said, "We will strengthen the cybersecurity response system in which the private and public sectors closely cooperate and establish a comprehensive information sharing analysis system between the private and public so that we can efficiently prevent and respond to cyber security threats."

No.3 Issue - SK Bioscience analyzed the cross-neutralization of booster shots through an extended study of phase 1/2 clinical trials of "SKYCovione GBP510," a synthetic antigen-type COVID-19 vaccine, and confirmed the immune response to the omicron variant.

81 healthy adults got additional vaccination about seven months after getting two doses of basic vaccination of SKYCovione. It turns out the number of neutralizing antibodies that can induce preventive effects by neutralizing omicron infection increased by about 25 times compared to immediately after the primary series. In addition, it was about 72 times higher compared to seven months after the final dose in the primary series(right before a booster).

No.4 Issue - Hankook Tire & Technology has newly launched its global brand "Laufenn" in the domestic market.

Laufenn is Hankook Tire's new brand that strategically target the global market to satisfy various tendencies and lifestyles of consumers around the world who aim for rational consumption.

Hankook Tire said, "Laufenn is characterized by its excellent quality, competitiveness and performance while having reasonable prices," adding, "It has already proven its technological prowess and more than 7 million units are being sold annually in 80 countries, including Europe and the United States, which are advanced automobile markets."

[Short News]
1. Kakao Brain-Galux conduct research on a new drug design platform based on AI
2. Naver Cloud launches a workbox e-contract service
3. Kakao Mobility opens a reservation service for Kakao T Taxi app and airport pickup service in Guam

Source: Pangyo Techno Valley Official Newsroom


# # #

Contact Information

CHA Seuk
Seoul, Seocho-gu
Republic of Korea
Voice: +8228563276
E-Mail: Email Us Here